Absolute efficacy of acellular pertussis vaccines in household settingsSTORSAETER, J; GUSTAFSSON, L.Developments in biological standardization. 1997, Num 89, pp 153-158, issn 0301-5149Conference Paper

Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trialTARANGER, J; TROLLFORS, B; KNUTSSON, N et al.Developments in biological standardization. 1997, Num 89, pp 109-112, issn 0301-5149Conference Paper

Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?GRANOFF, D. M; RAPPUOLI, R.Developments in biological standardization. 1997, Num 89, pp 379-389, issn 0301-5149Conference Paper

Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial IIHEIJBEL, H; RASMUSSEN, F; OLIN, P et al.Developments in biological standardization. 1997, Num 89, pp 99-100, issn 0301-5149Conference Paper

The effectiveness of whole-cell pertussis vaccinesPLOTKIN, S. A.Developments in biological standardization. 1997, Num 89, pp 171-174, issn 0301-5149Conference Paper

International Symposium on Pertussis Vaccine TrialsBROWN, Fred; GRECO, Donato; MASTRANTONIO, Paola et al.Developments in biological standardization. 1997, Num 89, issn 0301-5149, 423 p.Conference Proceedings

Absolute and relative efficacy of whole-cell vaccinesJAFARI, H. S.Developments in biological standardization. 1997, Num 89, pp 167-170, issn 0301-5149Conference Paper

Factors influencing antibody responses to acellular pertussis vaccinesTROLLFORS, B.Developments in biological standardization. 1997, Num 89, pp 279-282, issn 0301-5149Conference Paper

Japanese experience with 60 million doses of acellular pertussis vaccinesSATO, H.Developments in biological standardization. 1997, Num 89, pp 327-329, issn 0301-5149Conference Paper

Public health application of acellular pertussis vaccinesHADLER, S. C; ORENSTEIN, W. A.Developments in biological standardization. 1997, Num 89, pp 355-361, issn 0301-5149Conference Paper

Regulatory and standardization issuesWINSNES, R.Developments in biological standardization. 1997, Num 89, pp 349-350, issn 0301-5149Conference Paper

Methods for estimating serological correlates of protectionSIBER, G. R.Developments in biological standardization. 1997, Num 89, pp 283-296, issn 0301-5149Conference Paper

Preparation and composition of acellular pertussis vaccines. Consideration of potential effects on vaccine efficacyHEWLETT, E. L.Developments in biological standardization. 1997, Num 89, pp 143-151, issn 0301-5149Conference Paper

Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccinesHALLANDER, H. O.Developments in biological standardization. 1997, Num 89, pp 205-212, issn 0301-5149Conference Paper

Epidemiological determinants of pertussisMILLER, E; GAY, N. J.Developments in biological standardization. 1997, Num 89, pp 15-23, issn 0301-5149Conference Paper

Epidemiology of pertussis and use of acellular pertussis vaccines in JapanKUNO-SAKAI, H; KIMURA, M.Developments in biological standardization. 1997, Num 89, pp 331-332, issn 0301-5149Conference Paper

Safety of acellular pertussis vaccine : Follow-up studiesCHEN, R. T.Developments in biological standardization. 1997, Num 89, pp 373-375, issn 0301-5149Conference Paper

The United States research strategy on pertussisLA MONTAGNE, J. R.Developments in biological standardization. 1997, Num 89, pp 25-28, issn 0301-5149Conference Paper

Acellular pertussis vaccines : The next stepHALPERIN, S. A.Developments in biological standardization. 1997, Num 89, pp 363-365, issn 0301-5149Conference Paper

Diagnostic polymerase chain reactionREIZENSTEIN, E.Developments in biological standardization. 1997, Num 89, pp 247-254, issn 0301-5149Conference Paper

Isolation, identification and characterization of Bordetella pertussisGUISO, N.Developments in biological standardization. 1997, Num 89, pp 233-238, issn 0301-5149Conference Paper

Pertussis : A worldwide problemIVANOFF, B; ROBERTSON, S. E.Developments in biological standardization. 1997, Num 89, pp 3-13, issn 0301-5149Conference Paper

Public health implications : United KingdomMILLER, E.Developments in biological standardization. 1997, Num 89, pp 367-368, issn 0301-5149Conference Paper

The role of Bordetella pertussis infections in adults in the epidemiology of pertussisCHERRY, J. D.Developments in biological standardization. 1997, Num 89, pp 181-186, issn 0301-5149Conference Paper

Common side effects in the Italian and Stockholm I trialsTOZZI, A. E; OLIN, P.Developments in biological standardization. 1997, Num 89, pp 105-108, issn 0301-5149Conference Paper